Meeting Eye-to-Eye: A Patient-Provider Exchange on Improving Treatment in nAMD Through Sustained Delivery - a podcast by ReachMD

CME credits: 0.50

Valid until: 30-11-2021

Claim your CME credit at https://reachmd.com/programs/cme/meeting-eye-to-eye-a-patient-provider-exchange-on-improving-treatment-in-namd-through-sustained/11937/

The incidence of neovascular age-related macular degeneration (nAMD) is rising as a large segment of the US population ages. Despite recent advances in treatment, frequent injections and monitoring visits create a burden on patients that often leads to nonadherence, undertreatment, and suboptimal visual outcomes. In this unique educational activity, a patient with nAMD and 2 experts in retinal disease treatment discuss unmet needs in nAMD, strategies to reduce treatment burden using current therapies, and emerging strategies that harness either an implantable port or viral vectors to deliver anti–vascular endothelial growth factor therapy continuously to the vitreous. The desired results of this educational activity are for retina specialists and other ophthalmologists to use current evidence to support patient-centered treatment strategies for nAMD that minimize treatment burden while maximizing vision and quality of life outcomes.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD